Project Twenty21 - February Update

It’s been a very busy start to the year, with lots of change happening and expansion in the pipeline for the project - so there's so much to update you on. We've got loads of events coming up, so scroll down to get them in your diary.

As mentioned in our last newsletter, we have been having further discussions with the project's licensed-producer partners about the prescription price review. This has been going well and we hope to have some good news to share with you soon but we've decided that there will be no change on 1st March as we had previously announced. Instead, we will let you know through our mailing list, website and Drug Science social channels when a final decision has been reached on the pricing and when it will come into force.

Good news on clinic costs too. We now have three clinics offering initial consultations at under £100. As of this week, The Medical Cannabis Clinics have reduced their first appointment cost for Project Twenty21 patients to £70, and we're excited to announce that MyAccess Clinics are now taking on new patients with the study.

Something that's come to our attention recently is that some medical cannabis patients are under the impression that they have been signed up to Project Twenty21 when in actual fact they have never been registered. If you're not receiving questionnaires to fill in every 3 months, then it is unlikely you are registered with the project. Make sure you contact your clinic to check you are a Project Twenty21 patient and they can set this up for you if you're not already on our system. You can email our team if you need our support.

That way you can join the 2200 patients already contributing their data to help us move closer to our goal of medical cannabis access on the NHS.

Patient quote of the month

"I can finally relax on an evening with reduced pain, and I sleep better than I have in years which has a positive effect on my daytime pain and fatigue levels. I have also been able to reduce my pregabalin dose.”
- Fibromyalgia patient, aged 42

If you’re a T21 patient, you can share your own experience with us by filling out this form.

Our January data

This month's data nugget

MyAccess Clinics rejoin the project

We’re thrilled to announce that My Access Clinics has rejoined the project. The clinic’s Medical Director, Dr Sunil Arora, has begun taking on new patients, acting as lead clinician for Project Twenty21. He is one of the most experienced medical cannabis prescribers in the UK, and currently co-chairs the Medical Cannabis Sub Committee for the Cannabis Industry Council. 

Dr Arora said: "It is a pleasure to be back with T21 and support patient access to a medical product. I look forward to helping patients who require this medication for their quality of life".

Initial consultations are priced at £99, then £50 for follow-ups. Contact the clinic via our Clinic Directory to request to join Project Twenty21 as a patient. 

Read more about this in Cannabis Health.

‘The Truth About Cannabis’ FREE virtual conference

Following on from the success of our virtual conference ‘Working in Drug Science’ last October, we’re holding another evening of fascinating talks from expert speakers on 23rd March. This time we will be focusing on cannabis! 

The Truth About Cannabis will take you on a journey through some of the different perspectives within the cannabis space: spanning scientific, medical, technological and recreational. We have a line-up of expert speakers who are going to be putting the record straight on all things cannabis, including our very own Prof. David Nutt kicking off the evening of talks.

Tickets are free, so register now and block out your diary!

Watch ‘Medical Cannabis Prescribing for GPs’

Last month, we hosted a special virtual evening conference aimed at GPs, and now it's available for everyone to watch for free on our YouTube channel!

To help plug the gap in medical cannabis knowledge amongst GPs, the conference provided a unique opportunity for medical professionals to gain an understanding of current legislation, how GP prescribing works in places where it is already legal, such as the Channel Islands, Australia and Canada, and how doctors can get involved in medical cannabis prescribing at this current time in the UK. The evening was CPD-accredited and featured a presentation and discussion of the PCCN 2021 Survey from Founder of the PCCN and UK GP, Dr Leon Barron.

A huge thank you to all our speakers (not all of whom are below) who kindly gave their time to be part of the event!

Project Twenty21 launches in Australia

Known as Project Twenty21 Australia, the new study will be run in collaboration with the Australasian College of Cannabinoid Medicine (also known as ACCM, and the research arm of Releaf Group Ltd).

The Australian study will complement our work in the UK by collecting data on the efficacy and safety of medicinal cannabis in the treatment of four key conditions in the Australian population: chronic pain, anxiety, Post Traumatic Stress Disorder (PTSD) and multiple sclerosis.

Events & Webinars

3 Prescriptions in 3 Years: House of Lords medical cannabis event (invite only) - 22nd February
Postponed from last November due to Covid, Drug Science and Medcan Support are back at the House of Lords to speak to policy makers and charities about medical cannabis for treating children with epilepsy.

Drug Science Talks Cannabis (students only) - 24th February
We're speaking (albeit virtually) to students at Cardiff University, in collaboration with the Cardiff Drug Science Student Society, about access to medical cannabis, how it's prescribed and more about the exciting research happening at Drug Science in this area. Sign up here.  

Medical Cannabis Explained (training for medical professionals) - 2nd March
Our next CPD certified training session for medical professionals is a perfect opportunity for doctors to ask questions face-to-face with our Clinical Director, Prof Mike Barnes. Find out more and register.

CannX conference (in-person, Tel Aviv) - 14-15th March
Prof Mike Barnes, our Chief Medical Officer, will be speaking at this in-person conference. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists, clinicians, entrepreneurs, investors, policy makers and thought leaders for the ultimate opportunity to make an impact in the field. More information here.

The Truth About Cannabis: virtual conference - 23rd March
An evening discussing all things cannabis, from many different perspectives in the industry Speakers will include Prof David Nutt, Prof Mike Barnes and many special guests from various leading industry organisations. Register to attend for free here.

The Future of Medical Cannabis in the UK: Improving Patient Wellbeing and Supporting Innovation - 24th March
The Drug Science team will be presenting on the latest data from Project Twenty21 and our wider medical cannabis research. This virtual symposium will enable medical professionals, legislative figures, campaigners and other key stakeholders the opportunity to review both existing and potential policy on medical cannabis, aiming to practically address concerns and formulate strategies for future innovation. Register for your place here.

Action For Change: Drug Policy London Symposium (in-person & live-streamed) - 24th April
Our Honorary Research Assistant, Rayyan Zafar, is on the speaker line-up for this London-based event run by the Psychedelic Society. Rayyan will be speaking at this conference-style event about why we've only seen 3 whole plant medical cannabis prescriptions in the past 3 years and what needs to change to enable better access to this medicine. Hosted by of Project Twenty21, Mags Houston.  Buy tickets here.

How can you help?

As we analyse the data and receive more and more stories from patients, the importance of Project Twenty21 has never been clearer.

If you’d like to support Project Twenty21, to help us gather evidence for medical cannabis to be covered by the NHS, please consider a donation to Drug Science. Every little bit helps us continue the essential work that we do.


Missed our January update? Read what we were up to last month here.

Copyright © 2021 DrugScience, All rights reserved.

Click here to become part of the Drug Science Community!

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Drug Science is the leading independent scientific body on drugs in the UK. We work to provide clear, evidence-based information without political or commercial interference.

Twitter: @Drug_Science @ProfDavidNutt